Friday, February 14, 2025
Home Tags AAD

Tag: AAD

AAD 2023: Late-Breaking Phase III Results Demonstrate nemolizumab’s Significant … –...

0
Extensive updates from broad and innovative portfolio also to be presented The 2023 American Academy of Dermatology (AAD) Annual Meeting will see the...

Press release: Late-breaking Phase 3 data at AAD 2022 show Dupixent®...

0
Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularisDupixent significantly reduced itch at 12...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News